Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells

J Biol Chem. 2022 Apr;298(4):101747. doi: 10.1016/j.jbc.2022.101747. Epub 2022 Feb 19.

Abstract

While glucocorticoids act via the glucocorticoid receptor (GR; NR3C1) to reduce the expression of many inflammatory genes, repression is not an invariable outcome. Here, we explore synergy occurring between synthetic glucocorticoids (dexamethasone and budesonide) and proinflammatory cytokines (IL1B and TNF) on the expression of the toll-like receptor 2 (TLR2). This effect is observed in epithelial cell lines and both undifferentiated and differentiated primary human bronchial epithelial cells (pHBECs). In A549 cells, IL1B-plus-glucocorticoid-induced TLR2 expression required nuclear factor (NF)-κB and GR. Likewise, in A549 cells, BEAS-2B cells, and pHBECs, chromatin immunoprecipitation identified GR- and NF-κB/p65-binding regions ∼32 kb (R1) and ∼7.3 kb (R2) upstream of the TLR2 gene. Treatment of BEAS-2B cells with TNF or/and dexamethasone followed by global run-on sequencing confirmed transcriptional activity at these regions. Furthermore, cloning R1 or R2 into luciferase reporters revealed transcriptional activation by budesonide or IL1B, respectively, while R1+R2 juxtaposition enabled synergistic activation by IL1B and budesonide. In addition, small-molecule inhibitors and siRNA knockdown showed p38α MAPK to negatively regulate both IL1B-induced TLR2 expression and R1+R2 reporter activity. Finally, agonism of IL1B-plus-dexamethasone-induced TLR2 in A549 cells and pHBECs stimulated NF-κB- and interferon regulatory factor-dependent reporter activity and chemokine release. We conclude that glucocorticoid-plus-cytokine-driven synergy at TLR2 involves GR and NF-κB acting via specific enhancer regions, which combined with the inhibition of p38α MAPK promotes TLR2 expression. Subsequent inflammatory effects that occur following TLR2 agonism may be pertinent in severe neutrophilic asthma or chronic obstructive pulmonary disease, where glucocorticoid-based therapies are less efficacious.

Keywords: NF-κB; airway inflammation; cell signaling; chromatin immunoprecipitation; gene transcription; glucocorticoid receptor; p38 MAPK; toll-like receptor 2.

MeSH terms

  • Asthma* / physiopathology
  • Budesonide / pharmacology
  • Cytokines / metabolism
  • Dexamethasone / pharmacology
  • Epithelial Cells / metabolism
  • Gene Expression Regulation / drug effects
  • Glucocorticoids / pharmacology
  • Humans
  • Lung / cytology
  • Lung / metabolism
  • NF-kappa B* / metabolism
  • Receptors, Glucocorticoid* / metabolism
  • Toll-Like Receptor 2* / genetics
  • Toll-Like Receptor 2* / metabolism
  • p38 Mitogen-Activated Protein Kinases* / metabolism

Substances

  • Cytokines
  • Glucocorticoids
  • NF-kappa B
  • Receptors, Glucocorticoid
  • TLR2 protein, human
  • Toll-Like Receptor 2
  • Budesonide
  • Dexamethasone
  • p38 Mitogen-Activated Protein Kinases